COOThe Cooper Companies
Valuation
What COO's price assumes
The Cooper Companies trades at 21.4× earnings against 32.7× for the median Medical Instruments & Supplies name.
Trailing P/E · Medical Instruments & Supplies median 32.7 · 0.65× the Medical Instruments & Supplies median
- Price / sales
- 2.80
Price / sales · today's price, trailing year to Jul 31, 2026
- Free cash flow yield
- 5.7%
Free cash flow yield · Medical Instruments & Supplies median 3.6%
- Growth the price implies
- +3.9%
Growth the price implies · The price pays for +3.9% free cash flow growth a year for a decade; the business has delivered +45% a year over the last three.
Details›
- Price / booktoday's price, trailing year to Jul 31, 2026
- 1.42
- EV / EBITtoday's price, trailing year to Jul 31, 2026
- 27.3
- EV / salestoday's price, trailing year to Jul 31, 2026
- 3.51
- Healthcare median P/E497 names
- 27.1
- Medical Instruments & Supplies median P/E32 names
- 32.7
- Free cash flow, trailing twelve months
- $678M
- Market capitalisation190.2 million shares, counted Sep 3, 2026
- $11.9B
- 3-year revenue growth
- +6.4%
- 3-year free cash flow growth
- +45%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.
Medical Instruments & Supplies
The closest names by size in the same industry